Efficacy and Safety of a Single Low-dose Primaquine for the Clearance of Gametocytes
Status:
Completed
Trial end date:
2014-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess efficacy and safety of a single low-dose Primaquine
added to standard artemether/lumefantrine treatment for the clearance of Plasmodium
falciparum gametocytes among patients with uncomplicated malaria aged 1 year and above
regardless of their G6PD status.
Phase:
Phase 4
Details
Lead Sponsor:
Muhimbili University of Health and Allied Sciences
Collaborator:
Karolinska Institutet
Treatments:
Artemether Artemether-lumefantrine combination Artemether, Lumefantrine Drug Combination Artemisinins Lumefantrine Primaquine